These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 22932974)
1. Perspectives for a vaccine against hepatitis delta virus. Roggendorf M Semin Liver Dis; 2012 Aug; 32(3):256-61. PubMed ID: 22932974 [TBL] [Abstract][Full Text] [Related]
2. Vaccination against hepatitis delta virus infection: studies in the woodchuck (Marmota monax) model. Fiedler M; Roggendorf M Intervirology; 2001; 44(2-3):154-61. PubMed ID: 11509876 [TBL] [Abstract][Full Text] [Related]
3. Prime/boost immunization with DNA and adenoviral vectors protects from hepatitis D virus (HDV) infection after simultaneous infection with HDV and woodchuck hepatitis virus. Fiedler M; Kosinska A; Schumann A; Brovko O; Walker A; Lu M; Johrden L; Mayer A; Wildner O; Roggendorf M J Virol; 2013 Jul; 87(13):7708-16. PubMed ID: 23637419 [TBL] [Abstract][Full Text] [Related]
4. Immunization of woodchucks (Marmota monax) with hepatitis delta virus DNA vaccine. Fiedler M; Lu M; Siegel F; Whipple J; Roggendorf M Vaccine; 2001 Sep; 19(32):4618-26. PubMed ID: 11535309 [TBL] [Abstract][Full Text] [Related]
5. DNA-Based immunization produces Th1 immune responses to hepatitis delta virus in a mouse model. Huang YH; Wu JC; Tao MH; Syu WJ; Hsu SC; Chi WK; Chang FY; Lee SD Hepatology; 2000 Jul; 32(1):104-10. PubMed ID: 10869296 [TBL] [Abstract][Full Text] [Related]
6. Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8 Karimzadeh H; Kiraithe MM; Kosinska AD; Glaser M; Fiedler M; Oberhardt V; Salimi Alizei E; Hofmann M; Mok JY; Nguyen M; van Esch WJE; Budeus B; Grabowski J; Homs M; Olivero A; Keyvani H; Rodríguez-Frías F; Tabernero D; Buti M; Heinold A; Alavian SM; Bauer T; Schulze Zur Wiesch J; Raziorrouh B; Hoffmann D; Smedile A; Rizzetto M; Wedemeyer H; Timm J; Antes I; Neumann-Haefelin C; Protzer U; Roggendorf M J Virol; 2018 Jul; 92(13):. PubMed ID: 29669837 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea. Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950 [TBL] [Abstract][Full Text] [Related]
8. [The intrahepatic expression of the hepatitis B virus in chronic delta hepatitis]. Ramalho F; Velosa J; Costa A; Baptista A; de Moura MC Acta Med Port; 1993 May; 6(5):187-91. PubMed ID: 8337951 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis delta virus and the host response: current status and future perspectives. Thomas HC; Karayiannis P; Monjardino J; McNair A Prog Clin Biol Res; 1993; 382():431-5. PubMed ID: 8502714 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis D virus: an update. Pascarella S; Negro F Liver Int; 2011 Jan; 31(1):7-21. PubMed ID: 20880077 [TBL] [Abstract][Full Text] [Related]
11. Immunisation of woodchucks with hepatitis delta antigen expressed by recombinant vaccinia and baculoviruses, controls HDV superinfection. Karayiannis P; Saldanha J; Monjardino J; Jackson A; Luther S; Thomas HC Prog Clin Biol Res; 1993; 382():193-9. PubMed ID: 8502679 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis D virus infection in liver tissues of patients with hepatitis B in China. Hao LJ; Li L; Zhang YY; Song PH Chin Med J (Engl); 1992 Mar; 105(3):204-8. PubMed ID: 1395839 [TBL] [Abstract][Full Text] [Related]
14. Kinetics of WHV-HDV replication in acute fatal course of woodchuck hepatitis. D'Ugo E; Canitano A; Catone S; Argentini C; Giuseppetti R; Orobello S; Palmieri G; Rapicetta M Arch Virol; 2008; 153(11):2069-76. PubMed ID: 18985276 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis delta in HIV-infected individuals in Europe. Soriano V; Grint D; d'Arminio Monforte A; Horban A; Leen C; Poveda E; Antunes F; de Wit S; Lundgren J; Rockstroh J; Peters L AIDS; 2011 Oct; 25(16):1987-92. PubMed ID: 21857493 [TBL] [Abstract][Full Text] [Related]
16. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation. Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488 [TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of hepatitis delta virus infection. Karayiannis P; Saldanha J; Monjardino J; Farci P; Thomas HC Prog Clin Biol Res; 1991; 364():377-83. PubMed ID: 2020712 [TBL] [Abstract][Full Text] [Related]
18. Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections. Burm R; Maravelia P; Ahlen G; Ciesek S; Caro Perez N; Pasetto A; Urban S; Van Houtte F; Verhoye L; Wedemeyer H; Johansson M; Frelin L; Sällberg M; Meuleman P Gut; 2023 Jun; 72(6):1186-1195. PubMed ID: 35977815 [TBL] [Abstract][Full Text] [Related]
19. Latest discoveries on the infection and coinfection with hepatitis D virus. Bean P Am Clin Lab; 2002 Jun; 21(5):25-7. PubMed ID: 12122781 [TBL] [Abstract][Full Text] [Related]
20. The effects of using recombinant vaccinia viruses expressing either large or small HDAg to protect woodchuck hepadnavirus carriers from HDV superinfection. Eckart MR; Dong C; Houghton M; D'Urso N; Ponzetto A Prog Clin Biol Res; 1993; 382():201-5. PubMed ID: 8502680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]